12:00 AM
 | 
Dec 17, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Trans sodium crocetinate: Phase II started

Diffusion began the Phase II portion of an open-label, U.S. Phase I/II trial of IV TSC plus radiation therapy and temozolomide following an independent safety monitoring committee review of safety data from the Phase...

Read the full 146 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >